nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—VDR—asthma	0.456	1	CbGaD
Paricalcitol—CYP3A4—Fluticasone furoate—asthma	0.0241	0.0796	CbGbCtD
Paricalcitol—CYP3A4—Budesonide—asthma	0.0215	0.0709	CbGbCtD
Paricalcitol—CYP3A4—Indacaterol—asthma	0.0196	0.0649	CbGbCtD
Paricalcitol—CYP3A4—Ciclesonide—asthma	0.0196	0.0649	CbGbCtD
Paricalcitol—CYP3A4—Salbutamol—asthma	0.0183	0.0603	CbGbCtD
Paricalcitol—CYP3A4—Flunisolide—asthma	0.0183	0.0603	CbGbCtD
Paricalcitol—CYP3A4—Salmeterol—asthma	0.0183	0.0603	CbGbCtD
Paricalcitol—CYP3A4—Ipratropium bromide—asthma	0.0163	0.0538	CbGbCtD
Paricalcitol—CYP3A4—Zileuton—asthma	0.0163	0.0538	CbGbCtD
Paricalcitol—CYP3A4—Fluticasone Propionate—asthma	0.0155	0.0513	CbGbCtD
Paricalcitol—CYP3A4—Zafirlukast—asthma	0.0143	0.0473	CbGbCtD
Paricalcitol—CYP3A4—Tiotropium—asthma	0.0123	0.0407	CbGbCtD
Paricalcitol—CYP3A4—Aminophylline—asthma	0.0118	0.0389	CbGbCtD
Paricalcitol—CYP3A4—Theophylline—asthma	0.0111	0.0365	CbGbCtD
Paricalcitol—CYP3A4—Montelukast—asthma	0.0105	0.0346	CbGbCtD
Paricalcitol—CYP3A4—Loratadine—asthma	0.0105	0.0346	CbGbCtD
Paricalcitol—CYP3A4—Methylprednisolone—asthma	0.00959	0.0317	CbGbCtD
Paricalcitol—CYP3A4—Triamcinolone—asthma	0.00727	0.024	CbGbCtD
Paricalcitol—CYP3A4—Betamethasone—asthma	0.00623	0.0206	CbGbCtD
Paricalcitol—CYP3A4—Prednisolone—asthma	0.00615	0.0203	CbGbCtD
Paricalcitol—CYP3A4—Hydrocortisone—asthma	0.00583	0.0193	CbGbCtD
Paricalcitol—CYP3A4—Prednisone—asthma	0.00581	0.0192	CbGbCtD
Paricalcitol—CYP3A4—Dexamethasone—asthma	0.00363	0.012	CbGbCtD
Paricalcitol—UGT1A4—respiratory system—asthma	0.0028	0.154	CbGeAlD
Paricalcitol—CYP24A1—bronchus—asthma	0.00231	0.127	CbGeAlD
Paricalcitol—CYP24A1—trachea—asthma	0.00207	0.114	CbGeAlD
Paricalcitol—UGT1A4—Heme degradation—HMOX1—asthma	0.00171	0.0698	CbGpPWpGaD
Paricalcitol—VDR—respiratory system—asthma	0.00154	0.0851	CbGeAlD
Paricalcitol—CYP24A1—lung—asthma	0.00149	0.082	CbGeAlD
Paricalcitol—CYP24A1—Vitamin D Metabolism—VDR—asthma	0.00137	0.0556	CbGpPWpGaD
Paricalcitol—VDR—adrenal cortex—asthma	0.0013	0.0714	CbGeAlD
Paricalcitol—VDR—epithelium—asthma	0.00129	0.0711	CbGeAlD
Paricalcitol—VDR—bronchus—asthma	0.00127	0.07	CbGeAlD
Paricalcitol—VDR—cardiovascular system—asthma	0.00118	0.0651	CbGeAlD
Paricalcitol—Dihydrotachysterol—VDR—asthma	0.00116	0.232	CrCbGaD
Paricalcitol—VDR—trachea—asthma	0.00114	0.0629	CbGeAlD
Paricalcitol—VDR—adrenal gland—asthma	0.000935	0.0515	CbGeAlD
Paricalcitol—CYP24A1—Metapathway biotransformation—HNMT—asthma	0.000865	0.0352	CbGpPWpGaD
Paricalcitol—VDR—lung—asthma	0.00082	0.0452	CbGeAlD
Paricalcitol—Alfacalcidol—VDR—asthma	0.000746	0.149	CrCbGaD
Paricalcitol—Calcipotriol—VDR—asthma	0.000746	0.149	CrCbGaD
Paricalcitol—Calcidiol—VDR—asthma	0.000746	0.149	CrCbGaD
Paricalcitol—UGT1A4—Porphyrin metabolism—HMOX1—asthma	0.000745	0.0304	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—HNMT—asthma	0.000692	0.0282	CbGpPWpGaD
Paricalcitol—Calcitriol—VDR—asthma	0.000665	0.133	CrCbGaD
Paricalcitol—VDR—Ovarian Infertility Genes—ESR2—asthma	0.000568	0.0231	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—PRMT1—asthma	0.000559	0.0228	CbGpPWpGaD
Paricalcitol—Ergocalciferol—VDR—asthma	0.000532	0.106	CrCbGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	0.000513	0.0209	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—ESR2—asthma	0.000495	0.0202	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL12B—asthma	0.000428	0.0174	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—asthma	0.000426	0.0173	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—ALDH2—asthma	0.000424	0.0173	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—SMAD3—asthma	0.000422	0.0172	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—NQO1—asthma	0.000409	0.0166	CbGpPWpGaD
Paricalcitol—Cholecalciferol—VDR—asthma	0.000403	0.0807	CrCbGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—ESR2—asthma	0.000391	0.0159	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—NQO1—asthma	0.000377	0.0153	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of steroid hormones and vitamin D—POMC—asthma	0.000361	0.0147	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—NR3C1—asthma	0.000354	0.0144	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—BCL2—asthma	0.000307	0.0125	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—GATA3—asthma	0.000301	0.0123	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GSTT1—asthma	0.000293	0.0119	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—IL5—asthma	0.000285	0.0116	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR3C1—asthma	0.00028	0.0114	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—CARM1—asthma	0.000232	0.00945	CbGpPWpGaD
Paricalcitol—CYP3A4—Aflatoxin B1 metabolism—GSTM1—asthma	0.000229	0.00934	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—ALDH2—asthma	0.000225	0.00917	CbGpPWpGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—POMC—asthma	0.000224	0.00912	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTT1—asthma	0.000214	0.00872	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—asthma	0.000211	0.0086	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SERPINA1—asthma	0.000211	0.00859	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—PRMT1—asthma	0.000211	0.00858	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—IL10—asthma	0.000209	0.0085	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LTC4S—asthma	0.000204	0.00831	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GSTP1—asthma	0.000203	0.00826	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—SMAD3—asthma	0.000201	0.00818	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—asthma	0.000197	0.00803	CbGpPWpGaD
Paricalcitol—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—asthma	0.000195	0.00795	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—NR3C1—asthma	0.000193	0.00787	CbGpPWpGaD
Paricalcitol—UGT1A4—Phase II conjugation—GSTM1—asthma	0.000186	0.00759	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IFNG—asthma	0.000184	0.0075	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—POMC—asthma	0.000181	0.00739	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—ALDH2—asthma	0.00018	0.00733	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—BDKRB2—asthma	0.000178	0.00724	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LTA4H—asthma	0.000177	0.00721	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—CDK2—asthma	0.000174	0.0071	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTT1—asthma	0.000171	0.00697	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL1B—asthma	0.000164	0.00669	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—asthma	0.000164	0.00666	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—NQO1—asthma	0.000162	0.00661	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTP1—asthma	0.000148	0.00604	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—GSTP1—asthma	0.000146	0.00596	CbGpPWpGaD
Paricalcitol—CYP3A4—Estrogen metabolism—NQO1—asthma	0.00014	0.00572	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GSTM1—asthma	0.000136	0.00555	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—GSTP1—asthma	0.000135	0.00551	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—asthma	0.000135	0.00549	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—GSTM1—asthma	0.000135	0.00548	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—HMOX1—asthma	0.000133	0.00543	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—asthma	0.000128	0.0052	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—asthma	0.000125	0.0051	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—GSTM1—asthma	0.000124	0.00506	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—AGER—asthma	0.00012	0.00488	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—asthma	0.000119	0.00485	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTP1—asthma	0.000119	0.00483	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—GSTP1—asthma	0.000117	0.00477	CbGpPWpGaD
Paricalcitol—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—asthma	0.000116	0.00472	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—HNMT—asthma	0.000112	0.00457	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALOX15—asthma	0.000111	0.00453	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	0.000111	0.00453	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GSTM1—asthma	0.000109	0.00444	CbGpPWpGaD
Paricalcitol—CYP3A4—Estrogen metabolism—GSTM1—asthma	0.000108	0.00439	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—GSTM1—asthma	0.000108	0.00438	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—PDGFB—asthma	0.000107	0.00435	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CHAT—asthma	0.000106	0.00432	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—POMC—asthma	9.64e-05	0.00393	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALOX5—asthma	9.45e-05	0.00385	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LTC4S—asthma	9.09e-05	0.0037	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CARM1—asthma	9.02e-05	0.00367	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—CARM1—asthma	8.99e-05	0.00366	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PRMT5—asthma	8.86e-05	0.00361	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—SERPINE1—asthma	8.7e-05	0.00354	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—ALDH2—asthma	8.39e-05	0.00342	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—BCL2—asthma	8e-05	0.00326	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LTA4H—asthma	7.88e-05	0.00321	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—POMC—asthma	7.71e-05	0.00314	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LTC4S—asthma	7.27e-05	0.00296	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PARP1—asthma	7.14e-05	0.00291	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ARG1—asthma	6.89e-05	0.00281	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—ESR2—asthma	6.76e-05	0.00275	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—asthma	6.66e-05	0.00271	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—PTEN—asthma	6.62e-05	0.0027	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LTA4H—asthma	6.3e-05	0.00257	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALDH7A1—asthma	6.23e-05	0.00254	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ARG2—asthma	5.97e-05	0.00243	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ARG1—asthma	5.51e-05	0.00224	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—asthma	5.5e-05	0.00224	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—EGFR—asthma	5.38e-05	0.00219	CbGpPWpGaD
Paricalcitol—CYP3A4—Tryptophan metabolism—CAT—asthma	5.38e-05	0.00219	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	5.24e-05	0.00213	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB1—asthma	5.07e-05	0.00206	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—SMAD3—asthma	5.03e-05	0.00205	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALDH7A1—asthma	4.98e-05	0.00203	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALOX5AP—asthma	4.95e-05	0.00202	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALOX15—asthma	4.95e-05	0.00202	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NR3C1—asthma	4.83e-05	0.00197	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ARG2—asthma	4.78e-05	0.00195	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CHAT—asthma	4.72e-05	0.00192	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—CARM1—asthma	4.33e-05	0.00176	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALOX5—asthma	4.21e-05	0.00171	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CARM1—asthma	4.02e-05	0.00164	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—DCN—asthma	3.96e-05	0.00161	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALOX5AP—asthma	3.96e-05	0.00161	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALOX15—asthma	3.96e-05	0.00161	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALDH2—asthma	3.85e-05	0.00157	CbGpPWpGaD
Paricalcitol—Discomfort—Prednisolone—asthma	3.79e-05	0.000196	CcSEcCtD
Paricalcitol—Angioedema—Triamcinolone—asthma	3.79e-05	0.000196	CcSEcCtD
Paricalcitol—Angioedema—Methylprednisolone—asthma	3.78e-05	0.000195	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CHAT—asthma	3.78e-05	0.00154	CbGpPWpGaD
Paricalcitol—Myalgia—Hydrocortisone—asthma	3.75e-05	0.000194	CcSEcCtD
Paricalcitol—Malaise—Triamcinolone—asthma	3.74e-05	0.000193	CcSEcCtD
Paricalcitol—Anxiety—Hydrocortisone—asthma	3.74e-05	0.000193	CcSEcCtD
Paricalcitol—Malaise—Methylprednisolone—asthma	3.73e-05	0.000193	CcSEcCtD
Paricalcitol—Vertigo—Triamcinolone—asthma	3.73e-05	0.000193	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	3.72e-05	0.000192	CcSEcCtD
Paricalcitol—Syncope—Triamcinolone—asthma	3.72e-05	0.000192	CcSEcCtD
Paricalcitol—Vertigo—Methylprednisolone—asthma	3.72e-05	0.000192	CcSEcCtD
Paricalcitol—Syncope—Methylprednisolone—asthma	3.71e-05	0.000192	CcSEcCtD
Paricalcitol—Discomfort—Hydrocortisone—asthma	3.71e-05	0.000192	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—POMC—asthma	3.7e-05	0.00151	CbGpPWpGaD
Paricalcitol—Connective tissue disorder—Prednisone—asthma	3.7e-05	0.000191	CcSEcCtD
Paricalcitol—Nausea—Budesonide—asthma	3.69e-05	0.000191	CcSEcCtD
Paricalcitol—Oedema—Prednisolone—asthma	3.68e-05	0.00019	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTT1—asthma	3.66e-05	0.00149	CbGpPWpGaD
Paricalcitol—Loss of consciousness—Triamcinolone—asthma	3.65e-05	0.000188	CcSEcCtD
Paricalcitol—Loss of consciousness—Methylprednisolone—asthma	3.64e-05	0.000188	CcSEcCtD
Paricalcitol—VDR—Gene Expression—DNMT1—asthma	3.63e-05	0.00148	CbGpPWpGaD
Paricalcitol—Shock—Prednisolone—asthma	3.62e-05	0.000187	CcSEcCtD
Paricalcitol—Cough—Triamcinolone—asthma	3.62e-05	0.000187	CcSEcCtD
Paricalcitol—Oedema—Hydrocortisone—asthma	3.59e-05	0.000186	CcSEcCtD
Paricalcitol—Hypertension—Triamcinolone—asthma	3.58e-05	0.000185	CcSEcCtD
Paricalcitol—Hypertension—Methylprednisolone—asthma	3.57e-05	0.000185	CcSEcCtD
Paricalcitol—Infection—Hydrocortisone—asthma	3.57e-05	0.000185	CcSEcCtD
Paricalcitol—Hyperhidrosis—Prednisolone—asthma	3.56e-05	0.000184	CcSEcCtD
Paricalcitol—Shock—Hydrocortisone—asthma	3.54e-05	0.000183	CcSEcCtD
Paricalcitol—Myalgia—Triamcinolone—asthma	3.53e-05	0.000183	CcSEcCtD
Paricalcitol—Nervous system disorder—Hydrocortisone—asthma	3.53e-05	0.000182	CcSEcCtD
Paricalcitol—Myalgia—Methylprednisolone—asthma	3.52e-05	0.000182	CcSEcCtD
Paricalcitol—Arthralgia—Methylprednisolone—asthma	3.52e-05	0.000182	CcSEcCtD
Paricalcitol—Eye disorder—Prednisone—asthma	3.52e-05	0.000182	CcSEcCtD
Paricalcitol—Anxiety—Methylprednisolone—asthma	3.51e-05	0.000181	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	3.5e-05	0.000181	CcSEcCtD
Paricalcitol—Skin disorder—Hydrocortisone—asthma	3.49e-05	0.00018	CcSEcCtD
Paricalcitol—Ill-defined disorder—Dexamethasone—asthma	3.49e-05	0.00018	CcSEcCtD
Paricalcitol—Ill-defined disorder—Betamethasone—asthma	3.49e-05	0.00018	CcSEcCtD
Paricalcitol—Discomfort—Triamcinolone—asthma	3.49e-05	0.00018	CcSEcCtD
Paricalcitol—Discomfort—Methylprednisolone—asthma	3.48e-05	0.00018	CcSEcCtD
Paricalcitol—Hyperhidrosis—Hydrocortisone—asthma	3.48e-05	0.00018	CcSEcCtD
Paricalcitol—Dry mouth—Triamcinolone—asthma	3.45e-05	0.000178	CcSEcCtD
Paricalcitol—Angioedema—Dexamethasone—asthma	3.44e-05	0.000178	CcSEcCtD
Paricalcitol—Angioedema—Betamethasone—asthma	3.44e-05	0.000178	CcSEcCtD
Paricalcitol—VDR—Gene Expression—PARP1—asthma	3.44e-05	0.0014	CbGpPWpGaD
Paricalcitol—Anorexia—Hydrocortisone—asthma	3.43e-05	0.000177	CcSEcCtD
Paricalcitol—Angiopathy—Prednisone—asthma	3.42e-05	0.000177	CcSEcCtD
Paricalcitol—Confusional state—Methylprednisolone—asthma	3.41e-05	0.000176	CcSEcCtD
Paricalcitol—Immune system disorder—Prednisone—asthma	3.4e-05	0.000176	CcSEcCtD
Paricalcitol—Malaise—Betamethasone—asthma	3.39e-05	0.000175	CcSEcCtD
Paricalcitol—Malaise—Dexamethasone—asthma	3.39e-05	0.000175	CcSEcCtD
Paricalcitol—Oedema—Triamcinolone—asthma	3.39e-05	0.000175	CcSEcCtD
Paricalcitol—Vertigo—Betamethasone—asthma	3.38e-05	0.000175	CcSEcCtD
Paricalcitol—Vertigo—Dexamethasone—asthma	3.38e-05	0.000175	CcSEcCtD
Paricalcitol—Syncope—Betamethasone—asthma	3.37e-05	0.000174	CcSEcCtD
Paricalcitol—Syncope—Dexamethasone—asthma	3.37e-05	0.000174	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—asthma	3.37e-05	0.00137	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—SERPINE1—asthma	3.37e-05	0.00137	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALOX5—asthma	3.36e-05	0.00137	CbGpPWpGaD
Paricalcitol—Arrhythmia—Prednisone—asthma	3.36e-05	0.000174	CcSEcCtD
Paricalcitol—Infection—Triamcinolone—asthma	3.36e-05	0.000174	CcSEcCtD
Paricalcitol—Hypotension—Hydrocortisone—asthma	3.36e-05	0.000174	CcSEcCtD
Paricalcitol—Infection—Methylprednisolone—asthma	3.36e-05	0.000173	CcSEcCtD
Paricalcitol—Shock—Triamcinolone—asthma	3.33e-05	0.000172	CcSEcCtD
Paricalcitol—Insomnia—Prednisolone—asthma	3.33e-05	0.000172	CcSEcCtD
Paricalcitol—Alopecia—Prednisone—asthma	3.33e-05	0.000172	CcSEcCtD
Paricalcitol—Shock—Methylprednisolone—asthma	3.32e-05	0.000172	CcSEcCtD
Paricalcitol—Nervous system disorder—Methylprednisolone—asthma	3.31e-05	0.000171	CcSEcCtD
Paricalcitol—Loss of consciousness—Betamethasone—asthma	3.31e-05	0.000171	CcSEcCtD
Paricalcitol—Loss of consciousness—Dexamethasone—asthma	3.31e-05	0.000171	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisolone—asthma	3.31e-05	0.000171	CcSEcCtD
Paricalcitol—Mental disorder—Prednisone—asthma	3.3e-05	0.00017	CcSEcCtD
Paricalcitol—Skin disorder—Methylprednisolone—asthma	3.28e-05	0.00017	CcSEcCtD
Paricalcitol—Malnutrition—Prednisone—asthma	3.28e-05	0.000169	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Hydrocortisone—asthma	3.28e-05	0.000169	CcSEcCtD
Paricalcitol—Hyperhidrosis—Triamcinolone—asthma	3.27e-05	0.000169	CcSEcCtD
Paricalcitol—Hyperhidrosis—Methylprednisolone—asthma	3.27e-05	0.000169	CcSEcCtD
Paricalcitol—VDR—Gene Expression—ESR2—asthma	3.26e-05	0.00133	CbGpPWpGaD
Paricalcitol—Insomnia—Hydrocortisone—asthma	3.25e-05	0.000168	CcSEcCtD
Paricalcitol—Hypertension—Dexamethasone—asthma	3.25e-05	0.000168	CcSEcCtD
Paricalcitol—Hypertension—Betamethasone—asthma	3.25e-05	0.000168	CcSEcCtD
Paricalcitol—Paraesthesia—Hydrocortisone—asthma	3.23e-05	0.000167	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CARM1—asthma	3.21e-05	0.00131	CbGpPWpGaD
Paricalcitol—Myalgia—Dexamethasone—asthma	3.2e-05	0.000166	CcSEcCtD
Paricalcitol—Myalgia—Betamethasone—asthma	3.2e-05	0.000166	CcSEcCtD
Paricalcitol—Anxiety—Betamethasone—asthma	3.19e-05	0.000165	CcSEcCtD
Paricalcitol—Anxiety—Dexamethasone—asthma	3.19e-05	0.000165	CcSEcCtD
Paricalcitol—Discomfort—Betamethasone—asthma	3.17e-05	0.000164	CcSEcCtD
Paricalcitol—Discomfort—Dexamethasone—asthma	3.17e-05	0.000164	CcSEcCtD
Paricalcitol—Dyspepsia—Hydrocortisone—asthma	3.16e-05	0.000164	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—DCN—asthma	3.16e-05	0.00129	CbGpPWpGaD
Paricalcitol—Hypotension—Methylprednisolone—asthma	3.16e-05	0.000163	CcSEcCtD
Paricalcitol—Pain—Prednisolone—asthma	3.15e-05	0.000163	CcSEcCtD
Paricalcitol—Decreased appetite—Hydrocortisone—asthma	3.13e-05	0.000162	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Hydrocortisone—asthma	3.1e-05	0.00016	CcSEcCtD
Paricalcitol—Fatigue—Hydrocortisone—asthma	3.1e-05	0.00016	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Triamcinolone—asthma	3.08e-05	0.000159	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ALDH2—asthma	3.08e-05	0.00125	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Methylprednisolone—asthma	3.08e-05	0.000159	CcSEcCtD
Paricalcitol—Pain—Hydrocortisone—asthma	3.07e-05	0.000159	CcSEcCtD
Paricalcitol—Oedema—Dexamethasone—asthma	3.07e-05	0.000159	CcSEcCtD
Paricalcitol—Oedema—Betamethasone—asthma	3.07e-05	0.000159	CcSEcCtD
Paricalcitol—Insomnia—Triamcinolone—asthma	3.06e-05	0.000158	CcSEcCtD
Paricalcitol—Insomnia—Methylprednisolone—asthma	3.05e-05	0.000158	CcSEcCtD
Paricalcitol—Infection—Dexamethasone—asthma	3.05e-05	0.000158	CcSEcCtD
Paricalcitol—Infection—Betamethasone—asthma	3.05e-05	0.000158	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—NQO1—asthma	3.04e-05	0.00124	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Prednisone—asthma	3.04e-05	0.000157	CcSEcCtD
Paricalcitol—Paraesthesia—Triamcinolone—asthma	3.04e-05	0.000157	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisolone—asthma	3.03e-05	0.000157	CcSEcCtD
Paricalcitol—Paraesthesia—Methylprednisolone—asthma	3.03e-05	0.000157	CcSEcCtD
Paricalcitol—Anaemia—Prednisone—asthma	3.03e-05	0.000157	CcSEcCtD
Paricalcitol—Shock—Dexamethasone—asthma	3.02e-05	0.000156	CcSEcCtD
Paricalcitol—Shock—Betamethasone—asthma	3.02e-05	0.000156	CcSEcCtD
Paricalcitol—Dyspnoea—Triamcinolone—asthma	3.02e-05	0.000156	CcSEcCtD
Paricalcitol—Nervous system disorder—Dexamethasone—asthma	3.01e-05	0.000156	CcSEcCtD
Paricalcitol—Nervous system disorder—Betamethasone—asthma	3.01e-05	0.000156	CcSEcCtD
Paricalcitol—Agitation—Prednisone—asthma	3.01e-05	0.000156	CcSEcCtD
Paricalcitol—Angioedema—Prednisone—asthma	2.99e-05	0.000155	CcSEcCtD
Paricalcitol—Dyspepsia—Triamcinolone—asthma	2.98e-05	0.000154	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ADCY2—asthma	2.98e-05	0.00121	CbGpPWpGaD
Paricalcitol—Dyspepsia—Methylprednisolone—asthma	2.97e-05	0.000154	CcSEcCtD
Paricalcitol—Hyperhidrosis—Dexamethasone—asthma	2.97e-05	0.000153	CcSEcCtD
Paricalcitol—Hyperhidrosis—Betamethasone—asthma	2.97e-05	0.000153	CcSEcCtD
Paricalcitol—Feeling abnormal—Hydrocortisone—asthma	2.96e-05	0.000153	CcSEcCtD
Paricalcitol—Malaise—Prednisone—asthma	2.96e-05	0.000153	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.95e-05	0.0012	CbGpPWpGaD
Paricalcitol—Vertigo—Prednisone—asthma	2.94e-05	0.000152	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Hydrocortisone—asthma	2.94e-05	0.000152	CcSEcCtD
Paricalcitol—Syncope—Prednisone—asthma	2.94e-05	0.000152	CcSEcCtD
Paricalcitol—Anorexia—Betamethasone—asthma	2.93e-05	0.000151	CcSEcCtD
Paricalcitol—Anorexia—Dexamethasone—asthma	2.93e-05	0.000151	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTT1—asthma	2.93e-05	0.00119	CbGpPWpGaD
Paricalcitol—Urticaria—Prednisolone—asthma	2.92e-05	0.000151	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—ALDH2—asthma	2.92e-05	0.00119	CbGpPWpGaD
Paricalcitol—Fatigue—Triamcinolone—asthma	2.92e-05	0.000151	CcSEcCtD
Paricalcitol—Fatigue—Methylprednisolone—asthma	2.91e-05	0.000151	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	2.9e-05	0.00118	CbGpPWpGaD
Paricalcitol—Pain—Triamcinolone—asthma	2.89e-05	0.00015	CcSEcCtD
Paricalcitol—Loss of consciousness—Prednisone—asthma	2.88e-05	0.000149	CcSEcCtD
Paricalcitol—Hypotension—Dexamethasone—asthma	2.87e-05	0.000148	CcSEcCtD
Paricalcitol—Hypotension—Betamethasone—asthma	2.87e-05	0.000148	CcSEcCtD
Paricalcitol—Urticaria—Hydrocortisone—asthma	2.86e-05	0.000148	CcSEcCtD
Paricalcitol—Abdominal pain—Hydrocortisone—asthma	2.84e-05	0.000147	CcSEcCtD
Paricalcitol—Body temperature increased—Hydrocortisone—asthma	2.84e-05	0.000147	CcSEcCtD
Paricalcitol—Hypertension—Prednisone—asthma	2.83e-05	0.000146	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Dexamethasone—asthma	2.8e-05	0.000145	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Betamethasone—asthma	2.8e-05	0.000145	CcSEcCtD
Paricalcitol—Arthralgia—Prednisone—asthma	2.79e-05	0.000144	CcSEcCtD
Paricalcitol—Myalgia—Prednisone—asthma	2.79e-05	0.000144	CcSEcCtD
Paricalcitol—Feeling abnormal—Triamcinolone—asthma	2.79e-05	0.000144	CcSEcCtD
Paricalcitol—Feeling abnormal—Methylprednisolone—asthma	2.78e-05	0.000144	CcSEcCtD
Paricalcitol—Anxiety—Prednisone—asthma	2.78e-05	0.000144	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTT1—asthma	2.78e-05	0.00113	CbGpPWpGaD
Paricalcitol—Insomnia—Dexamethasone—asthma	2.78e-05	0.000144	CcSEcCtD
Paricalcitol—Insomnia—Betamethasone—asthma	2.78e-05	0.000144	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	2.77e-05	0.000143	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Methylprednisolone—asthma	2.76e-05	0.000143	CcSEcCtD
Paricalcitol—Paraesthesia—Dexamethasone—asthma	2.76e-05	0.000143	CcSEcCtD
Paricalcitol—Paraesthesia—Betamethasone—asthma	2.76e-05	0.000143	CcSEcCtD
Paricalcitol—Discomfort—Prednisone—asthma	2.76e-05	0.000142	CcSEcCtD
Paricalcitol—Hypersensitivity—Prednisolone—asthma	2.71e-05	0.00014	CcSEcCtD
Paricalcitol—Dyspepsia—Dexamethasone—asthma	2.7e-05	0.00014	CcSEcCtD
Paricalcitol—Dyspepsia—Betamethasone—asthma	2.7e-05	0.00014	CcSEcCtD
Paricalcitol—Urticaria—Triamcinolone—asthma	2.69e-05	0.000139	CcSEcCtD
Paricalcitol—Urticaria—Methylprednisolone—asthma	2.68e-05	0.000139	CcSEcCtD
Paricalcitol—Body temperature increased—Triamcinolone—asthma	2.68e-05	0.000138	CcSEcCtD
Paricalcitol—Oedema—Prednisone—asthma	2.67e-05	0.000138	CcSEcCtD
Paricalcitol—Abdominal pain—Methylprednisolone—asthma	2.67e-05	0.000138	CcSEcCtD
Paricalcitol—Decreased appetite—Betamethasone—asthma	2.67e-05	0.000138	CcSEcCtD
Paricalcitol—Decreased appetite—Dexamethasone—asthma	2.67e-05	0.000138	CcSEcCtD
Paricalcitol—Infection—Prednisone—asthma	2.66e-05	0.000137	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Dexamethasone—asthma	2.65e-05	0.000137	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Betamethasone—asthma	2.65e-05	0.000137	CcSEcCtD
Paricalcitol—Hypersensitivity—Hydrocortisone—asthma	2.65e-05	0.000137	CcSEcCtD
Paricalcitol—Fatigue—Dexamethasone—asthma	2.65e-05	0.000137	CcSEcCtD
Paricalcitol—Fatigue—Betamethasone—asthma	2.65e-05	0.000137	CcSEcCtD
Paricalcitol—Shock—Prednisone—asthma	2.63e-05	0.000136	CcSEcCtD
Paricalcitol—Pain—Dexamethasone—asthma	2.63e-05	0.000136	CcSEcCtD
Paricalcitol—Pain—Betamethasone—asthma	2.63e-05	0.000136	CcSEcCtD
Paricalcitol—Nervous system disorder—Prednisone—asthma	2.62e-05	0.000136	CcSEcCtD
Paricalcitol—Skin disorder—Prednisone—asthma	2.6e-05	0.000134	CcSEcCtD
Paricalcitol—Hyperhidrosis—Prednisone—asthma	2.59e-05	0.000134	CcSEcCtD
Paricalcitol—Asthenia—Hydrocortisone—asthma	2.58e-05	0.000133	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—asthma	2.57e-05	0.00105	CbGpPWpGaD
Paricalcitol—Anorexia—Prednisone—asthma	2.55e-05	0.000132	CcSEcCtD
Paricalcitol—Pruritus—Hydrocortisone—asthma	2.54e-05	0.000131	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—GSTP1—asthma	2.54e-05	0.00103	CbGpPWpGaD
Paricalcitol—Feeling abnormal—Betamethasone—asthma	2.53e-05	0.000131	CcSEcCtD
Paricalcitol—Feeling abnormal—Dexamethasone—asthma	2.53e-05	0.000131	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Betamethasone—asthma	2.51e-05	0.00013	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Dexamethasone—asthma	2.51e-05	0.00013	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—HMOX1—asthma	2.5e-05	0.00102	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ITPR1—asthma	2.5e-05	0.00102	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Triamcinolone—asthma	2.49e-05	0.000129	CcSEcCtD
Paricalcitol—Hypersensitivity—Methylprednisolone—asthma	2.49e-05	0.000129	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CAT—asthma	2.47e-05	0.00101	CbGpPWpGaD
Paricalcitol—Diarrhoea—Hydrocortisone—asthma	2.46e-05	0.000127	CcSEcCtD
Paricalcitol—Urticaria—Betamethasone—asthma	2.44e-05	0.000126	CcSEcCtD
Paricalcitol—Urticaria—Dexamethasone—asthma	2.44e-05	0.000126	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Prednisone—asthma	2.44e-05	0.000126	CcSEcCtD
Paricalcitol—Dizziness—Prednisolone—asthma	2.43e-05	0.000126	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—NQO1—asthma	2.43e-05	0.000991	CbGpPWpGaD
Paricalcitol—Asthenia—Triamcinolone—asthma	2.43e-05	0.000126	CcSEcCtD
Paricalcitol—Body temperature increased—Dexamethasone—asthma	2.43e-05	0.000125	CcSEcCtD
Paricalcitol—Abdominal pain—Betamethasone—asthma	2.43e-05	0.000125	CcSEcCtD
Paricalcitol—Body temperature increased—Betamethasone—asthma	2.43e-05	0.000125	CcSEcCtD
Paricalcitol—Abdominal pain—Dexamethasone—asthma	2.43e-05	0.000125	CcSEcCtD
Paricalcitol—Asthenia—Methylprednisolone—asthma	2.42e-05	0.000125	CcSEcCtD
Paricalcitol—VDR—Gene Expression—SMAD3—asthma	2.42e-05	0.000985	CbGpPWpGaD
Paricalcitol—Insomnia—Prednisone—asthma	2.42e-05	0.000125	CcSEcCtD
Paricalcitol—Paraesthesia—Prednisone—asthma	2.4e-05	0.000124	CcSEcCtD
Paricalcitol—Pruritus—Triamcinolone—asthma	2.39e-05	0.000124	CcSEcCtD
Paricalcitol—Pruritus—Methylprednisolone—asthma	2.39e-05	0.000124	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—ADCY2—asthma	2.38e-05	0.00097	CbGpPWpGaD
Paricalcitol—Dizziness—Hydrocortisone—asthma	2.38e-05	0.000123	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	2.35e-05	0.000959	CbGpPWpGaD
Paricalcitol—Dyspepsia—Prednisone—asthma	2.35e-05	0.000122	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PLA2G4A—asthma	2.33e-05	0.00095	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GSTM1—asthma	2.33e-05	0.00095	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR3C1—asthma	2.33e-05	0.000947	CbGpPWpGaD
Paricalcitol—Decreased appetite—Prednisone—asthma	2.33e-05	0.00012	CcSEcCtD
Paricalcitol—Rash—Prednisolone—asthma	2.32e-05	0.00012	CcSEcCtD
Paricalcitol—Dermatitis—Prednisolone—asthma	2.32e-05	0.00012	CcSEcCtD
Paricalcitol—VDR—Gene Expression—PPP2CA—asthma	2.31e-05	0.000943	CbGpPWpGaD
Paricalcitol—Diarrhoea—Methylprednisolone—asthma	2.31e-05	0.000119	CcSEcCtD
Paricalcitol—Fatigue—Prednisone—asthma	2.31e-05	0.000119	CcSEcCtD
Paricalcitol—Headache—Prednisolone—asthma	2.31e-05	0.000119	CcSEcCtD
Paricalcitol—Constipation—Prednisone—asthma	2.29e-05	0.000118	CcSEcCtD
Paricalcitol—Vomiting—Hydrocortisone—asthma	2.29e-05	0.000118	CcSEcCtD
Paricalcitol—Rash—Hydrocortisone—asthma	2.27e-05	0.000117	CcSEcCtD
Paricalcitol—Dermatitis—Hydrocortisone—asthma	2.26e-05	0.000117	CcSEcCtD
Paricalcitol—Headache—Hydrocortisone—asthma	2.25e-05	0.000116	CcSEcCtD
Paricalcitol—Dizziness—Triamcinolone—asthma	2.24e-05	0.000116	CcSEcCtD
Paricalcitol—Dizziness—Methylprednisolone—asthma	2.23e-05	0.000115	CcSEcCtD
Paricalcitol—Feeling abnormal—Prednisone—asthma	2.2e-05	0.000114	CcSEcCtD
Paricalcitol—Asthenia—Betamethasone—asthma	2.2e-05	0.000114	CcSEcCtD
Paricalcitol—Asthenia—Dexamethasone—asthma	2.2e-05	0.000114	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Prednisone—asthma	2.19e-05	0.000113	CcSEcCtD
Paricalcitol—Nausea—Prednisolone—asthma	2.19e-05	0.000113	CcSEcCtD
Paricalcitol—Pruritus—Dexamethasone—asthma	2.17e-05	0.000112	CcSEcCtD
Paricalcitol—Pruritus—Betamethasone—asthma	2.17e-05	0.000112	CcSEcCtD
Paricalcitol—Vomiting—Triamcinolone—asthma	2.15e-05	0.000111	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PPP2CA—asthma	2.15e-05	0.000875	CbGpPWpGaD
Paricalcitol—Vomiting—Methylprednisolone—asthma	2.15e-05	0.000111	CcSEcCtD
Paricalcitol—Nausea—Hydrocortisone—asthma	2.14e-05	0.00011	CcSEcCtD
Paricalcitol—Rash—Triamcinolone—asthma	2.13e-05	0.00011	CcSEcCtD
Paricalcitol—Dermatitis—Triamcinolone—asthma	2.13e-05	0.00011	CcSEcCtD
Paricalcitol—Rash—Methylprednisolone—asthma	2.13e-05	0.00011	CcSEcCtD
Paricalcitol—Dermatitis—Methylprednisolone—asthma	2.13e-05	0.00011	CcSEcCtD
Paricalcitol—Urticaria—Prednisone—asthma	2.12e-05	0.00011	CcSEcCtD
Paricalcitol—Headache—Triamcinolone—asthma	2.12e-05	0.00011	CcSEcCtD
Paricalcitol—Headache—Methylprednisolone—asthma	2.12e-05	0.000109	CcSEcCtD
Paricalcitol—Abdominal pain—Prednisone—asthma	2.11e-05	0.000109	CcSEcCtD
Paricalcitol—Body temperature increased—Prednisone—asthma	2.11e-05	0.000109	CcSEcCtD
Paricalcitol—Diarrhoea—Dexamethasone—asthma	2.1e-05	0.000109	CcSEcCtD
Paricalcitol—Diarrhoea—Betamethasone—asthma	2.1e-05	0.000109	CcSEcCtD
Paricalcitol—Dizziness—Dexamethasone—asthma	2.03e-05	0.000105	CcSEcCtD
Paricalcitol—Dizziness—Betamethasone—asthma	2.03e-05	0.000105	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—GSTP1—asthma	2.03e-05	0.000826	CbGpPWpGaD
Paricalcitol—Nausea—Triamcinolone—asthma	2.01e-05	0.000104	CcSEcCtD
Paricalcitol—Nausea—Methylprednisolone—asthma	2.01e-05	0.000104	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—HMOX1—asthma	2e-05	0.000815	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ITPR1—asthma	2e-05	0.000813	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CAT—asthma	1.97e-05	0.000804	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Prednisone—asthma	1.97e-05	0.000102	CcSEcCtD
Paricalcitol—Vomiting—Dexamethasone—asthma	1.95e-05	0.000101	CcSEcCtD
Paricalcitol—Vomiting—Betamethasone—asthma	1.95e-05	0.000101	CcSEcCtD
Paricalcitol—Rash—Betamethasone—asthma	1.94e-05	0.0001	CcSEcCtD
Paricalcitol—Rash—Dexamethasone—asthma	1.94e-05	0.0001	CcSEcCtD
Paricalcitol—Dermatitis—Dexamethasone—asthma	1.93e-05	0.0001	CcSEcCtD
Paricalcitol—Dermatitis—Betamethasone—asthma	1.93e-05	0.0001	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTP1—asthma	1.93e-05	0.000784	CbGpPWpGaD
Paricalcitol—Headache—Betamethasone—asthma	1.92e-05	9.95e-05	CcSEcCtD
Paricalcitol—Headache—Dexamethasone—asthma	1.92e-05	9.95e-05	CcSEcCtD
Paricalcitol—Asthenia—Prednisone—asthma	1.92e-05	9.92e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.9e-05	0.000774	CbGpPWpGaD
Paricalcitol—Pruritus—Prednisone—asthma	1.89e-05	9.78e-05	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—PLA2G4A—asthma	1.86e-05	0.000759	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GSTM1—asthma	1.86e-05	0.000759	CbGpPWpGaD
Paricalcitol—Diarrhoea—Prednisone—asthma	1.83e-05	9.46e-05	CcSEcCtD
Paricalcitol—Nausea—Betamethasone—asthma	1.82e-05	9.43e-05	CcSEcCtD
Paricalcitol—Nausea—Dexamethasone—asthma	1.82e-05	9.43e-05	CcSEcCtD
Paricalcitol—CYP3A4—Biological oxidations—GSTM1—asthma	1.77e-05	0.000721	CbGpPWpGaD
Paricalcitol—Dizziness—Prednisone—asthma	1.77e-05	9.14e-05	CcSEcCtD
Paricalcitol—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.75e-05	0.000711	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPP2CA—asthma	1.72e-05	0.000699	CbGpPWpGaD
Paricalcitol—Vomiting—Prednisone—asthma	1.7e-05	8.79e-05	CcSEcCtD
Paricalcitol—Rash—Prednisone—asthma	1.69e-05	8.72e-05	CcSEcCtD
Paricalcitol—Dermatitis—Prednisone—asthma	1.68e-05	8.71e-05	CcSEcCtD
Paricalcitol—Headache—Prednisone—asthma	1.68e-05	8.66e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—POMC—asthma	1.65e-05	0.000671	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SERPINE1—asthma	1.62e-05	0.000661	CbGpPWpGaD
Paricalcitol—Nausea—Prednisone—asthma	1.59e-05	8.21e-05	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—ALB—asthma	1.5e-05	0.000612	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NOS3—asthma	1.44e-05	0.000586	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—POMC—asthma	1.32e-05	0.000537	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—asthma	1.31e-05	0.000536	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—POMC—asthma	1.25e-05	0.000509	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—asthma	1.2e-05	0.000489	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LTC4S—asthma	1.18e-05	0.000481	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NOS3—asthma	1.15e-05	0.000468	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTEN—asthma	1.15e-05	0.000467	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—asthma	1.05e-05	0.000428	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LTA4H—asthma	1.02e-05	0.000417	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTEN—asthma	9.17e-06	0.000373	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ARG1—asthma	8.94e-06	0.000364	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDH7A1—asthma	8.09e-06	0.000329	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ARG2—asthma	7.75e-06	0.000316	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALOX15—asthma	6.42e-06	0.000262	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALOX5AP—asthma	6.42e-06	0.000262	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CHAT—asthma	6.13e-06	0.00025	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALOX5—asthma	5.46e-06	0.000222	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CARM1—asthma	5.21e-06	0.000212	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—DCN—asthma	5.14e-06	0.000209	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALDH2—asthma	5e-06	0.000203	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTT1—asthma	4.75e-06	0.000194	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NQO1—asthma	3.95e-06	0.000161	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ADCY2—asthma	3.86e-06	0.000157	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTP1—asthma	3.29e-06	0.000134	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMOX1—asthma	3.25e-06	0.000132	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ITPR1—asthma	3.24e-06	0.000132	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAT—asthma	3.2e-06	0.000131	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GSTM1—asthma	3.03e-06	0.000123	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLA2G4A—asthma	3.03e-06	0.000123	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPP2CA—asthma	2.79e-06	0.000114	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—POMC—asthma	2.14e-06	8.71e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—asthma	1.95e-06	7.94e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NOS3—asthma	1.87e-06	7.6e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—asthma	1.71e-06	6.95e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTEN—asthma	1.49e-06	6.06e-05	CbGpPWpGaD
